
T2 Biosystems TTOO
Quarterly report 2024-Q3
added 05-16-2026
T2 Biosystems Operating Cycle 2011-2026 | TTOO
Annual Operating Cycle T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.3 | 131 | 66.3 | 142 | 179 | 293 | 71.8 | 73.8 | 180 | 308 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 308 | 66.3 | 154 |
Quarterly Operating Cycle T2 Biosystems
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.8 | 67.8 | 66.4 | - | 74.4 | 60.4 | 76 | - | 53.3 | 54.7 | 59.9 | - | 50.4 | 54.6 | 59.9 | - | 88.7 | 182 | 142 | 84 | 154 | 143 | 118 | 90.9 | 66.1 | 41.5 | 44.5 | 25.7 | 38.5 | 44.6 | 38.5 | 32.8 | 27.5 | 30.1 | 29 | 33.3 | 32.1 | 59.7 | 138 | 154 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 182 | 25.7 | 72 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 203.29 | -0.59 % | $ 22.6 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 4.99 | 10.89 % | $ 6.64 M | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 21.13 | 0.24 % | $ 612 M | ||
|
Fulgent Genetics
FLGT
|
87 | $ 18.9 | 2.16 % | $ 582 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 145.57 | -4.12 % | $ 11.4 B | ||
|
Guardant Health
GH
|
128 | $ 130.25 | 0.1 % | $ 16.3 B | ||
|
Illumina
ILMN
|
204 | $ 162.88 | 1.78 % | $ 25.2 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 23.33 | 2.55 % | $ 1.24 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Interpace Biosciences
IDXG
|
96 | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 100.82 | 0.84 % | $ 6.8 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 186.79 | -1.69 % | $ 9.26 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
244 | $ 1.4 | 2.19 % | $ 420 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 466.95 | 0.03 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 137.25 | -2.21 % | $ 23.4 B | ||
|
NeoGenomics
NEO
|
102 | $ 11.29 | -1.35 % | $ 1.45 B | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.47 | -1.43 % | $ 414 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 21.03 | 6.48 % | $ 471 M | ||
|
Natera
NTRA
|
48.3 | $ 218.17 | -2.09 % | $ 29.8 B | ||
|
Personalis
PSNL
|
63.8 | $ 9.8 | 0.51 % | $ 875 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 25.71 | -2.98 % | $ 24.4 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 7.32 | -1.48 % | $ 305 M | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
204 | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 68.35 | -2.44 % | $ 4.09 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 267.67 | -1.3 % | $ 22.3 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 483.35 | -2.22 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.68 | 2.94 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.22 | -0.81 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M |